Home» Circulars» Viewcirculars Back
 
India Japan Regulatory Symposium, 18-19 May 2016, New Delhi
 

PxlHeaderLogo

Ref: PXL/H.O./CIR-013/2016-17                                                             Date: 13.05.2016

Hyderabad

India - Japan  Regulatory Symposium

May 18 - 19, 2016, Venue: Silver Oak, India Habitat Centre, New Delhi

To
All the Members of Council,

Dear Sir/Madam,

You are kindly aware of our efforts in exploring opportunities in Japan. For the last few years Pharmexcil has played a very significant role in bringing together industries and government in Japan to look towards India for opportunities in contract manufacturing, research and development and collaborations.  You are aware of our Brand India Pharma initiatives in Japan and sustained efforts through B2B and participation in CPhI-Tokyo.

 

Pharmexcil is pleased to inform that Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India in association with Ministry of Health & Labour Welfare, Government of Japan and PMDA (Pharmaceuticals and Medical Device Agency), Japan is organising the 1st India-Japan Medical Products Regulatory Symposium on May 18-19, 2016 at New Delhi, India.

 

The symposium emerges as a step to further the spirit of bilateral co-operation between both countries as set by the signing of Memorandum of Cooperation (MoC) between the regulators of India and Japan in December 2015, on Medical Products Regulation Dialogue and Cooperation Framework among others.

 

Objective: This is the first Government-to-Government industry Regulatory interaction that is open to Industry participation.

 

The upcoming Symposium aims at initiating a continued dialogue between the Regulatory authorities of both countries for Pharmaceuticals, Regenerative Medicine Products & Medical Devices. Regulatory harmonisation will be a key catalyst in realizing this untapped growth story of India. It is envisaged that benefits of trade exchange & technology exchange can be synergised in future for larger good.

 

It aspires to cultivate future collaborations which will usher in the fruits of shared R&D and economisation of healthcare costs through seamless adoption of innovations developed across shores.

 

The symposium will see participation of Regulators & Government’s Senior Regulators and Officials from both counties in addition to a vibrant industry mix ranging from start-ups to large corporates operating / originating from India and Japan and also interested in India – Japan regulatory and trade co –operations. Over 50 companies from Japan are also participating in the symposium.

 

The deliberations will offer deep insights in regulatory mechanisms of both countries for medical products and offer opportunities for networking, query resolution with key decision makers.

 

Participating in the Symposium allows you to learn about and influence the Regulatory framework from an Indo-Japan perspective.

 

We look forward for your kind confirmation for your presence at the symposium. Please send your confirmation on rodelhi@pharmexcil.comby 16th May 2016. The registrationform and tentative agendais attached herewith for your reference.

 

With regards

Dr. P V Appaji

Director General 

 

Encl:

Registration

Tentative Agenda

H.O.: 101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: +91-40-23735462/66, Fax: +91-40-23735464
Email: info@pharmexcil.com Website: www.pharmexcil.com